Bone Repair

Bone products in development are based on the years of research and knowledge gained from years of clinical trials with MSCs at Osiris. The XC project, utilizing culture expanded MSCs, leverages everything we have learned about cellular therapy, from clinical safety to large-scale manufacturing. Starting with XC, Biosurgery will produce practical, viable bone products designed to improve conditions that remain unaddressed in orthopedics.

Custom Solutions

• Different structures depending on the surgical application for bone fill indications that need accelerated bone formation and care.
• Optimal cell treatment to maximize cell persistence, density, and osteogenic potential
• Advanced understanding of product using state of the art immunologic and biologic assays.